Using Both Lactic Dehydrogenase Levels and the Ratio of Involved to Uninvolved Free Light Chain Levels as Risk Factors Improves Risk Assessment in Patients With Newly Diagnosed Multiple Myeloma-Reference-Cited by-同舟云学术

Using Both Lactic Dehydrogenase Levels and the Ratio of Involved to Uninvolved Free Light Chain Levels as Risk Factors Improves Risk Assessment in Patients With Newly Diagnosed Multiple Myeloma

Published:2018-04 Issue:4 Volume:355 Page:350-356
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Guo Zihua,Li Huijun,Geng Yudi,Cui Jian,Tang Ning,Li Dengju

Funder

National Natural Science Foundation

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

2. Multiple myeloma;Palumbo;N Engl J Med,2011

3. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders;Dispenzieri;Leukemia,2009

4. Chromosome 1 amplification has similar prognostic value to del(17p13) and t (4;14) (p16; q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group;Grzasko;Leuk Lymphoma,2017

5. Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value;An;Haematologica,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Common Blood Test Indexes in the Diagnosis and Prognosis of Multiple Myeloma;Clinical Laboratory;2022

2. Significance of Common Blood Test Indexes in the Diagnosis and Prognosis of Multiple Myeloma;CLIN LAB;2021

3. Serum Lactate Dehydrogenase Can Be Used as a Factor for Re-Evaluating First-Relapsed Multiple Myeloma;Acta Haematologica;2020